Pathologic stage-specific markers for diagnosing prognosis and determining treatment strategies of patients of clear cell renal cell carcinoma

摘要

The present invention relates to a marker for prognostic diagnosis or a difference in the therapeutic effect of kidney cancer according to the pathology grade of kidney cancer patients, and in kidney cancer patients, survival rate, recurrence rate, and overall mutation of the gene of the present invention and kidney cancer of a specific pathological grade Since the rates are each related, the mutated gene of the present invention can be used as a marker to predict a difference in the therapeutic effect of kidney cancer or the prognosis of a kidney cancer patient based on the pathology grade.